Feedback / Questions
Rinvoq (upadacitinib) - AbbVie
Dupixent (dupilumab) - Sanofi, Regeneron
https://www.hcplive.com/view/upadacitinib-switch-from-dupilumab-effective-head-neck-atopic-dermatitis
Feb 6, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next